Mumbai :
Emcure Pharmaceuticals is launching its IPO on July 3.
Investors can buy shares in this IPO, with the company aiming to raise Rs 1952.03 crore in total.
Out of this, Rs 800 crore will come from new shares, and Rs 1152.03 crore from existing shares.
Price Band and Lot Size
The share price band is set between Rs 960 and Rs 1008.
Each lot has 14 shares, so investors can buy at least one lot (14 shares) and at most 14 lots (196 shares).
This means the investment will range from Rs 14,112 to Rs 1,97,568.
The shares will be listed on BSE and NSE. Half of the IPO is reserved for institutional investors, 35% for retail investors, and 15% for non-institutional investors.
Use of Funds
The money raised will be used to repay Rs 600 crore of debt. Emcure had a debt of Rs 2,091.90 crore as of March 2024.
The rest of the funds will go towards general corporate needs. Kotak Mahindra Bank, JP Morgan India, Jefferies India, and Axis Capital are managing the IPO.
Key Dates
Important Dates are as follows:
- IPO Open: July 3-5
- Share Allotment: July 8
- Refund for Unsuccessful Investors: July 9
- Shares in Demat Accounts: July 9
- Listing Date: July 10, 2024
For financial health, see below
Financial Health
Emcure Pharma operates in India, Europe, and Canada. In the financial year 2024, 48.28% of its revenue came from India.
The company’s profit dropped by 6% to Rs 527.60 crore, but its earnings increased by 11.2% to Rs 6,658.30 crore.
